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Abstract
Background: We developed an efficient in vitro method to differentiate mouse ES cells into the definitive endoderm
(DE) and then Pdx1-expressing pancreatic lineages using mesodermal-derived supporting cells, M15. Using this
method, resulting ES cell-derived DE and Pdx1-expressing cells were isolated by cell sorting, and their gene
expression profiles were investigated with DNA microarray. Genes that were specifically expressed in DE and/or in
Pdx1-expressing cells were extracted and their expression patterns in normal embryonic development were studied.
Results: Genes whose expression increased in DE and Pdx1 positive cells compared to the undifferentiated ES cells
were chosen and in situ hybridizations were performed. Out of 54 genes examined, 27 were expressed in the DE
of E8.5 mouse embryos and 15 genes were expressed in distinct domains in the pancreatic buds of E14.5 embryos.
Among those genes expressed were Foxq1, CpM, Foxp4, Pcdh1, and Zmiz1, which were previously reported in other
endodermal tissues. Genes, such as Parm1, Tmem184a, Hipk2 and Sox4 were reported to be expressed during early
pancreatic development. Nptx2, C2cd4b, Tcf7l2 and Kiss1r were reported to be associated with beta cell or
pancreatic functions in the adult. Akr1c19, Aebp2, Pbxip1 and Creb3l1, were novel and have not been described as
being expressed either in DE or the pancreas.
Conclusions: We identified 27 genes, including 4 novel genes expressed in DE and pancreatic progenitor cells
during normal development using an ES cell in vitro differentiation system. These results showed that DE cells and
Pdx1/GFP-expressing cells obtained from our M15 based differentiation method mimic cells during the normal
developmental processes. Additionally, ES cells are an excellent model for studies of early developmental processes.
Background
The endoderm gives rise to the respiratory and digestive
organs such as pancreas, liver, lung, stomach, and intes-
tine. These developmental processes are of great impor-
tance in therapeutics. The multipotent endoderm has
the potential to be used to repair tissues. However, in
spite of the importance of the definitive endoderm (DE)
derived tissues, not much is known about how they
emerge from the primary gut tube. Fate mapping studies
suggest that the fate of the DE begins to segregate at
embryonic day 6-6.5 (E6-E6.5) and that the progenitors
that are fated to become specific tissues of the gut tube
appear shortly after the completion of gastrulation [1,2].
The expression of the regional specific transcription fac-
tors has provided clues to how the endoderm is pat-
terned into organ domains. In the chick, the progenitor
for stomach, pancreas and intestine are segregated
immediately after the completion of gastrulation. The
progenitors receive inducing signals from the adjacent
mesoderm during their migration and are specified
before they reach their final destination [3]. Pancreatic
and duodenal homeobox gene 1 (Pdx1)e x p r e s s i o ni sb y
far the first sign of pancreatic differentiation detected at
E8.5 in dorsal endoderm of the gut. Pdx1 is expressed
before the buds become evident, and is required for the
progression of pancreatic and rostral duodenal develop-
ment [4]. Genetic lineage tracing studies have shown
that the Pdx1-expressing cells give rise to all three cell
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duct cells.
Recent advances in analysis and identification of early
endodermal or pancreatic genes is remarkable [5-9]. Sev-
eral reports have demonstrated the identification of novel
endodermal genes using early embryos. Embryonic stem
(ES) cells are also a highly useful tool in the study of
endodermal development. ES cells are pluripotent cells
and can be cultured indefinitely in an undifferentiated
state, and stimulated to differentiate into various cell
types. Progress in ES cell studies has demonstrated that
ES cells provide a good system for studies of develop-
mental biology, in addition to the use of ES cells as a sur-
rogate cell source for regenerative medicine. Several
groups have reported the differentiation of mouse or
human ES cells into the DE or pancreatic lineages
[10,11]. We recently established a procedure, where ES
cells were cultured on a monolayer of mesodermal-
derived M15 cells, and sequentially induced into the
mesendoderm, DE and regional specific DE-derived
organs in vitro. This occurred in a manner that mimics
early embryonic inductive events in vivo [12,13]. With
the addition of activin and bFGF, mouse ES cells differen-
tiated into Pdx1-expressing cells efficiently, reaching 60%
of the DE [12]. This M15 procedure turned out not only
to be useful in directing DE lineages, but also the ecto-
derm and mesoderm lineages from ES cells, by altering
the culture conditions [14]. Using this M15 differentia-
tion procedure, we tried to validate the differentiated
cells by analyzing the expression profiles of three germ
layer cells and the pancreatic progenitor cells [14-16].
Comparison of the expression profiles between the cells
of the three germ layers, which are derived from the ES
cells based on this M15 procedure, revealed a clear dis-
tinct clustering of the genes specifically expressed in each
germ layer. Studies of Pdx1-exprssing cells derived from
ES cells led to the discovery of a novel pancreatic pro-
genitor marker, Eppk1 [15,17] and identification of a
n o v e ls u r f a c em a r k e r ,D A F 1 / C D 5 5 ,e x p r e s s e di nt h eD E
[16]. Therefore, it is feasible to identify genes related to
early DE development and pancreatic differentiation by
close investigation into the ES cell-derived cells.
Here we describe an extensive gene expression profile
analysis of ES cell-derived definitive endodermal cells
and Pdx1-expressing cells. We chose candidate genes by
the comparisons between ES cell-derived Pdx1-positive
or negative DE with the undifferentiated ES cells, ES
cell-derived ectoderm, mesendoderm and mesoderm
cells. Then we carried out whole mount or section in
situ hybridization using mouse embryos at E8.5 or pan-
creas at E14.5, respectively. Out of 54 candidate genes
examined, 27 candidate genes are expressed in the DE
at E8.5 and 15 genes are expressed in the pancreatic
bud at E14.5. These results indicate that the ES cell-
derived differentiated cells serve as good models for stu-
dies of candidate genes during early embryogenesis.
Results
Microarray analysis of ES cell-derived DE cell lineages
As previously described, we developed an efficient pro-
cedure using mesodermal-derived M15 cells as feeder
cells with the supplementation of activin and bFGF, to
sequentially differentiate ES cells into, mesendoderm
(MES) at day 4 (d4), DE (E-cadherin+/CXCR4+ popula-
tions) (d5 to d7) and then Pdx1-expressing cells (d8),
(Figure 1A) [12]. ES cells were also differentiated into
the three germ layers under different conditions (Shiraki
et al. 2009). Using these procedures, ES cell-derived
differentiated cells of the ectoderm (SSEA1-/Flk1-/
PGFRa-) (ECT), MES (E-cadherin+/PDGFRa+), lateral
plate mesoderm (E-cadherin-/PDGFRa-/Flk1+) (LPM),
paraxial mesoderm (E-cadherin-/PDGFRa+/Flk1-)
(PAM) and DE at d5, d7 and d8 were prospectively iso-
lated, by the expression of specific cell surface antigens
using flow cytometry. DE cells at d8 were further subdi-
vided into Pdx1/GFP-negative and -positive populations.
The efficiencies of the induction of individual pop-
ulations were similar to that previously reported
(Additional file 1). The values were as follows: MES
(12%; Additional file 1A), LPM (6%; Additional file 1B),
PAM (42%; Additional file 1B), d5DE (45%; Additional
file 1C), d5ECT (52%; Additional file 1D), d7DE (53%,
Additional file 1E), d8DE (67%), and d8DE Pdx1(-) (35%
x67% = 23%; Additional file 1F), or d8DE Pdx1+ (65%
x67% = 42%; Additional file 1F). Since ECT was done by
negative selection, we confirmed the purity of the ECT
using a Sox1/GFP ES cell line [14,18]. Ninety-four per-
cent of the sorted ECT turned out to be Sox1/GFP-posi-
tive neuroectoderm. RNA was extracted from these cells
and analyzed by Affymetrix DNA microarray. Then,
gene expression profiles of undifferentiated ES cells
( E S ) ,E Sc e l l - d e r i v e dE C T ,L P M ,P A M ,M E S ,d 5 D E ,
d7DE, Pdx1- d8DE and Pdx1+ d8DE, were compared. A
remarkable transition of the gene expression profile was
observed from d5DE to d7DE and thereafter (Figure 1B).
To validate the microarray results, we selected six repre-
sentative genes, which showed increased expression
levels at >7 fold changes in d8DE, compared to the
median signal intensities of other populations, namely
ES, ECT, LPM, PAM, MES and d5DE. We examined
the actual expression patterns of these genes in ES cell-
derived cells. Figure 1C shows the signal intensities of 6
genes: AI464131, Akr1c19, Foxp4, Hipk2, Pcbd1 and
Tmem184a, together with those of Sox17,a ne n d o d e r -
mal gene, and Pdx1, in each indicated population of ES
cell-derived cells obtained in the microarray (Figure 1C).
Then, transcription levels of the above genes were quan-
tified by real time PCR analysis (For primer sequences,
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Page 2 of 15Figure 1 Microarray analysis of ES cell-derived cells. (A) ES cells and ES cell-derived cells were isolated by the expression of cell surface
antigen as previously described [14]. Populations isolated were: ES cells (ES), ectoderm (ECT), mesendoderm (MES), lateral plate mesoderm,
(LPM); Paraxial mesoderm, (PAM) and DE at day 5 (D5), day 7 (D7) and day 8 (D8, DE Pdx1-, DE Pdx1+). (B) Clustering of gene expression in ES
cells, ECT, LPM, PAM, MES, d5DE, d7DE, d8DE Pdx1- and d8DE Pdx1+ cell lineages. Each line indicates an individual gene. Red lines indicate
genes with high expressions and green lines indicate genes with low expressions in the DE lineages. Y axis represents normalized value of the
expression level. (C) Microarray results and real time PCR analyses of six representative candidate genes, namely, AI464131, Akr1c19, Foxp4, Hipk2,
Pcbd1, and Tmem184a, together with Sox17, and Pdx1, as positive controls. Right Y-axis values represent GeneChip signal intensities of candidate
genes. Transcription levels of the representative candidate genes in each population are quantified by real-time PCR analysis. The transcription
levels are normalized with that of b-actin. The values are further normalized with that of Pdx1-positive DE on d8 (d8DE GFP+) and thus the left
Y-axis values represent relative gene expression levels when the expression level at d8 (d8DE GFP+) is defined as 100.
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Page 3 of 15see Additional file 2). The patterns of the quantitative
PCR results correlated well with the signal intensities
obtained in the microarray analyses (Figure 1C). The
high expression level of Sox 17 in d5DE, d7DE and
Pdx1 in d8DE Pdx1+ population, further confirmed the
characters of the ES cell-derived cell populations.
Identification of DE specific genes in ES cell-
differentiation
To identify genes involved in DE and pancreatic develop-
ment, we chose genes that showed raw expression levels
above 50 and increased expression in d5DE or d8DE Pdx1+
more than 5 fold change compared to the median signal
intensity of ES, ECT, LPM, PAM, MES, d5DE and d8DE
Pdx1+. As a result, 165 probe sets (127 genes) or 780 probe
sets (594 genes) showed increased transcripts at d5DE and
d8DE Pdx1+, respectively, with 115 probe sets (84 genes)
overlapping between the two populations. Thus, 50 probe
sets (43 genes) were specifically up regulated at d5DE, and
decreased thereafter. One hundred and fifteen probe sets
(84 genes) were up regulated through d5DE to d8DE Pdx1
+. Six hundred and sixty-five probe sets (594 genes) were
u pr e g u l a t e da td 8 D EP d x 1 + .
We then examined the expression pattern of some of
these DE specific genes in early stages of development.
Unknown genes, or genes with specific domain struc-
tures, transcription factors or genes whose expression in
the endoderm or early pancreas development have not
been described, were chosen and analyzed by whole
mount in situ hybridization. Figure 2 shows the sum-
mary of the numbers of genes analyzed and the genes,
which were positive in the expression in the gut endo-
derm at embryonic day (E) E8.5 (or E9.5 for Apoe)a n d /
or the pancreatic bud at E14.5 (Figure 2). Of the 115
probe sets (84 genes) that were up regulated at >5 fold
at d5 & d8DE Pdx1+, 12 genes were picked, 8 genes
were expressed in the E8.5 gut epithelium, and 4 genes
were expressed in E14.5 pancreas bud (Figure 2). Of the
665 probe sets (510 genes) that were up regulated at >5
fold at d8DE, 33 genes were examined, 16 genes were
expressed in the E8.5 gut epithelium, and 10 genes were
expressed in the E14.5 pancreatic bud. Additionally, we
randomly picked 4 genes whose expression increased at
d7DE at > 5 fold compared to d5DE, and 5 genes that
w e r ee x p r e s s e da td 8 D Ei nt h eP d x 1 +p o p u l a t i o na t> 2
fold compared to the Pdx1- population. Of the genes
examined, 2 and 1 genes were expressed in the E8.5 gut
epithelium, respectively, and 2 (1+1) genes were
expressed in E14.5 pancreas bud (Figure 2).
Genes up regulated in ES cell-derived DE cells are also
expressed in the gut endoderm at E8.5
A ss h o w ni nF i g u r e2 ,o u to f1 2g e n e se x a m i n e d ,t h e
expression of 8 genes, which increased at >5 fold at
d5DE through d8DE, were expressed in E8.5 or E9.5
endoderm. The 8 positive genes were: AI464131,
Akr1c19, DAF1/CD55, Foxq1, Nptx2, Pga5, Parm1 and
Tmem184a. Their expression patterns at E8.5 are
shown in Figure 3. AI464131 and Nptx2 were expressed
i nt h ew h o l eg u te n d o d e r mt h r o u g h o u tt h ea n t e r i o r - t o -
posterior region (Figure 3). Akr1c19 was expressed
weakly in the anterior intestinal portal (AIP, depicted by
an arrow) at E8.5, and in the liver bud, pancreas and
intestine epithelium at E9.5 (SH data not shown).
DAF1/CD55 expression is observed in the lateral gut
and AIP at E8.5, which was published earlier [16]
(Table 1). Similarly, Tmem184a was expressed in the
lateral gut and AIP at E8.5. Foxq1 was expressed
strongly in the AIP. Parm1 was expressed in the dorsal
anterior gut epithelium. Pga5 was expressed weakly in
the whole lateral gut epithelium. The regions positively
detected by in situ hybridization are marked by arrows
(Figure 3). Cross sections were made and representative
results of Parm1 and Tmem184a expressions are shown
(Figure 3).
Figure 2 Numbers of endoderm specific candidate genes.
Summary of the numbers of genes picked up for further analyses by
whole mount in situ hybridization (top). Numbers of genes that are
expressed in gut endoderm at E8.5 (middle) or the pancreatic bud at
E14.5 (bottom). Blue circle: genes expressed at >5 fold in d5DE; Red
circle: genes expressed at >5 fold in d8DE Pdx1+; Green circle: genes
expressed at >5 fold in d7DE versus d5DE; Brown circle, genes
expressed at >2 fold in d8DE Pdx1+ versus d8DE Pdx1-.
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Page 4 of 15The expression patterns by in situ hybridization in E8.5
(or E9.5 with Apoe gene) of 16 positive genes, whose
expression increased first at d8DE are shown in Figure 4A.
Apoe was expressed in the lateral endoderm and visceral
endoderm at E8.5 (SH unpublished) and strongly in the
liver bud at E9.5 (Figure 4A, Apoe,a r r o w ) .M o s tg e n e s ,
including Chi3l1, CpM, C2cd4b, Fam184b, Fhl2, Foxp4,
Hipk2, Lbh, Pcbd1, Pbxip1, Sox4, Tcf7l2 and Zmiz1, were
expressed in the anterior intestinal portal (AIP) in E8.5
embryos (Figure 4A, arrows). In addition to the AIP,
C2cd4b was also expressed in the hindgut; CpM, Foxp4
and Zmiz were also expressed in the lateral gut epithelium.
Irf6 was expressed in the anterior endoderm and hindgut
epithelium. The lateral gut epithelium expression of
Zmiz1 was shown by sectioning the E8.5 embryo after
in situ hybridization (Figure 4A, arrows). An Ig domain
gene, Palld1, was expressed in the dorsal gut epithelium,
also confirmed by sectioning the E8.5 embryo after in situ
hybridization (Figure 4A, arrow).
The followings are the expression patterns of the genes
that were up regulated at d7DE or d8DE, at >5 fold com-
p a r e dt od 5 D E( F i g u r e4 B )o ra ta> 2f o l di n c r e a s ei n
Pdx1+ versus Pdx1- population (Figure 4C): Among the
9 genes examined (Figure 2B, Table 1), Aebp2, Barhl and
Kiss1r were expressed in E8.5 embryos. Aebp2 was
strongly expressed in the whole gut tube, and Barhl2,
Kiss1r in the lateral gut epithelium (Figure 4B,C, arrows).
All genes described in Figure 3 and 4 are summarized in
Table 1, with their gene descriptions, Genbank number,
expression patterns in E8.5 endoderm, and previous publi-
cations on expression or function in the endoderm or pan-
creas. Although they have been implicated in the function
of pancreas or other endodermal derived organs, this
study showed, for the first time, the expression of many
genes in the early stage of development.
Genes expressed in distinct pancreas domains at E14.5
As described above, of the 54 genes analyzed, 27 genes
were expressed in the E8.5 gut epithelium (Figure 3, 4).
It was reported that transcripts of genes could be cate-
gorized based on their expression patterns into one of
five expression domain in the pancreas at E14.5 [5]. We
then examined all 54 genes for their expression in E14.5
pancreatic buds. Among the 54 genes, 15 genes are
expressed in E14.5 pancreatic buds. The expression pat-
terns were categorized (Figure 5, 6, Table 1). Aebp2,
AI464131, Akr1c19, Creb3l1, Foxp4, Hipk2, Pcbd1, Sox4,
Tcf7l2 and Tmem184a were expressed in the pancreas
epithelium (Figure 5). Pbxip1 and C2cd4b were
expressed in the trunk region (Figure 6A). Parm1 and
Pcdh1 were expressed in the tip region (Figure 6B).
AI464131, Creb3l1 and Tcf7l2 were also expressed in
the mesenchyme, in addition to their epithelial expres-
sions (Figure 6C). Pcdh1 was expressed only in the
mesenchyme (Figure 6C). Apoe was expressed in the
v a s c u l a rc e l l s( F i g u r e6 D ) .T h ea b o v eg e n ee x p r e s s i o n
domains in E14.5 pancreatic buds are summarized in
Table 1.
Figure 3 The expression pattern of 7 candidate genes, whose expression is increased at d5DE in E8.5 mouse definitive endoderm,
analyzed by in situ hybridization. In situ hybridization pictures of AI464131, Akr1c19, Foxq1, Pga5, Parm1, Nptx2 and Tmem184a are shown.
Arrows indicate the signals detected. Cross sections through the white line of Parm1 and Tmem184a are shown (right panels). A: anterior; P:
posterior. Scale bars: 100 μm.
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Page 5 of 15Table 1 A summary of the genes described in this work
Gene Description Genbank expression expression domain at
E14.5
Publication on gut or
pancreas
E8.5, endo Expression
or function
Publication
d5 DE > 5 and
d8 DE > 5,
compared with
ES, ECT, LPM,
PAM,
Mesendoderm,
d5 DE
AI464131 expressed sequence
AI464131
BG063189 whole gut epithelium mesenchyme ――
Akr1c19 aldo-keto reductase
family 1, member C19
BG073853 AIP epithelium ――
DAF1/CD55 decay accelerating
factor 1
NM_010016 AIP, lateral
gut
endoderm Cell Struct. Func.
2010
Foxq1 forkhead box Q1 NM_008239 AIP stomach Gastroenterogy,
2008
Nptx2 neuronal pentraxin 2 NM_016789 whole gut pancreatic
cancer
Cancer Epidemiol
Biomarkers Prev,
2008
Parm1 Riken cDNA
9130213B05 gene
NM_145562 anterior
endoderm
tip E10.5
pancreas
BMC Dev. Biol.,
2007
Pga5 pepsinogen 5,
group I
NM_021453 lateral gut ――
Tmem184a transmembrane
protein 184a
BC019731 AIP, lateral
gut
epithelium E12.5~,
pancreas
exocrine
Dev Dyn., 2009
d8 DE, Pdx1(GFP)
+> 5, compared
with ES, ECT,
LPM, PAM,
Mesendoderm,
d5 DE
APOE apolipoprotein E AK019319 visceral
endoderm
vascular ――
C2cd4b C2 calcium-
dependent domain
containing 4B
AK014341 AIP,
posterior
gut
trunk associated
with b-cell
function
Diabetologia.,2010
Chi3l1 chitinase 3-like 1 BC005611 AIP ――
CpM carboxypeptidase M AK004327 AIP, lateral
gut
lung Am. J. Respir. Cell
Mol. Biol. 1993
Creb3l1 cAMP responsive
element binding
protein 3-like 1
BC016447 - epithelium mesenchyme ――
Fam188b RIKEN cDNA
C330043M08 gene
BB667136 AIP ――
Fhl2 four and a half LIM
domains 2
NM_010212 AIP,
anterior
gut
――
Foxp4 forkhead box P4 BQ286886 AIP, lateral
gut
epithelium E9.5~,
pulmonary,
gut
Mech Dev. 2002
Hipk2 homeodomain
interacting protein
kinase 2
NM_010433 AIP epithelium E12.5~,
pancreas
Endocrinology,
2009
Irf6 interferon regulatory
factor 6
NM_016851 anterior
gut,
hindgut
――
Lbh Limb-bud-and-heart NM_029999 AIP ――
Palld 2410003B16Rik, Ig
domain Palladin
NM_001081390 dorsal gut ――
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Page 6 of 15Coexpression of the genes with endocrine and exocrine
markers in the pancreatic bud
To investigate further into the function of the genes,
their co-expression with the endocrine markers, namely
insulin and glucagon, or an exocrine marker, amylase,
and Pdx1 were examined.
C2cd4b, a gene expressed in the trunk (Figure 7A), was
co-expressed with insulin, but not glucagon, implicating
its function in endocrine b cell differentiation (Figure
7A). Hipk2 was co-expressed with glucagon, but not
insulin, implicating that it might associate with a cell dif-
ferentiation (Figure 7A). Akr1c19 was co-expressed with
Pdx1 or insulin, thus suggesting its possible function in
b cell differentiation (Figure 7A). Foxp4, Pcbd1 and
Aebp2, which are expressed in the epithelium, were
co-localized in part with amylase staining (Figure 7B).
Discussion
We previously reported the prospective isolation and
global expression profiles of the ES cells derived three
germ layer cells, such as the mesendoderm, ectoderm,
mesoderm and DE, which were obtained by culturing
ES cells on M15 [14]. Therefore, M15 provides a plat-
form to compare expression profiles of different lineages
derived from ES cells.
In our previous analyses, without the addition of acti-
vin and bFGF, but with M15 feeder cells, ES cells
derived into immature DE cells, and there were few
genes that were expressed in E14.5 pancreatic buds [15].
Here, we used a differentiation protocol with the supple-
mentation of activin and bFGF, a procedure that allows
for approximately 50-60% of the differentiated ES cells
to give rise to the DE, and among which 60% cells give
rise to Pdx1-expressing cells [12,14]. Under the present
protocol, ES cells differentiated into a pancreatic devel-
opmental pathway. Many genes expressed specifically in
the pancreas are identified by comparing d7DE or d8DE
with other populations. This may explain the reason for
the small differences between GFP+ and GFP- popula-
tion, since GFP- population are committed to a similar
developmental pathway. Using this protocol, we effi-
ciently identified genes specifically expressed in the DE
and the pancreatic lineage.
We also examined in our ES cell-derived cells, the
expression levels of genes enriched the E7.5 embryo
endoderm (Additional file 3) [19], E8.25 endoderm
(Additional file 4) [7], and E10.5 Pdx1+ cells (Additional
file 5) [19]. Many of the enriched genes in DE of E7.5
embryos were also found to be up-regulated in our
ES cell-derived d5DE, d7DE and d8DE GFP+ cells
(Additional file 3). Of the endoderm enriched genes in
E8.25 embryos, genes such as Spink3, Clic6, FoxA1,
Krt7, Crb3, Ell3, Rab15 Rbm35a, St14 and Tmprss2 are
expressed at a higher level in d7DE or d8DE than d5DE.
Table 1 A summary of the genes described in this work (Continued)
Pbxip1 pre-B-cell leukemia
transcription factor
interacting protein 1
AV220340 AIP trunk ――
Pcbd1 pterin 4 alpha
carbinolamine
dehydratase/
dimerization cofactor
of hepatocyte nuclear
factor 1 (TCF1)
NM_025273 AIP epithelium ―
Pcdh1 protocadherin 1 AK008111 - tip mesenchyme E12.5~
blood
vessels of
the gut
Dev Dyn.,2008
Sox4 SRY-box containing
gene 4
AI428101 AIP, lateral
gut
epithelium E12.4~,
pancreas
Dev Dyn.,2003
Tcf7l2 transcription factor
7-like 2, T-cell specific,
HMG-box
BM218908 AIP, lateral
gut
epithelium mesenchyme diabetes risk
gene
Nat. Genet.2006
Zmiz1 zinc finger, MIZ-type
containing 1
NM_183208 AIP, lateral
gut
―
d7 DE/d5 DE > 5 Aebp2 AE binding protein 2 BB667191 whole gut epithelium ――
Barhl2 BarH-like 2
(Drosophila)
NM_001005477 lateral gut ――
d8 DE Pdx1(GFP)
+/Pdx1(GFP)- > 2
Kiss1r KISS1 receptor NM_053244 lateral gut mouse islets Diabetologia.,2006
All genes up regulated >5 folds in d5DE, d7DE or d8DE, and their expressions are observed in E8.5 endoderm or E14.5 pancreatic buds are listed. Descriptions,
Genbank number, expression patterns in E8.5 endoderm, E14.5 pancreatic buds, and previous publications are summarized.
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Page 7 of 15Figure 4 The expression pattern of 18 candidate genes, whose expression is increased, at d8DE, in E8.5 mouse definitive endoderm,
analyzed by in situ hybridization. (A) The expression of 16 candidate genes, whose expression is increased >5 fold in d8DE Pdx1/GFP+
population, (B) >5 fold in d7DE versus d5DE, or (C) >2 fold in d8DE Pdx1+ versus Pdx1- cells, are shown. Gene names are indicated at top of the
pictures. Arrows indicate the sites detected. Cross sections through the white line of Palld1 or Zmiz1 are shown (right panels). A: anterior; P:
posterior. Scale bars: 100 μm.
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Page 8 of 15Figure 5 The expression of 10 candidate genes in E14.5 pancreas epithelium. Aebp2, AI464131, Akr1c19, Creb3l1, Foxp4, Hipk2, Pcbd1, Sox4,
Tcf7l2 and Tmem184a are expressed in the pancreas epithelium, detected by in situ hybridization. Parts of the pancreas epithelia are out lined
with dotted lines. Scale bar: 100 μm, applied to all pictures.
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Page 9 of 15Figure 6 The expression of candidate genes in E14.5 pancreas distinct regions.( A )Pbxip1 and C2cd4b are expressed in the trunk region.
(B) Parm1 and Pcdh1 are in the tip region. (C) AI464131, Creb3l1, Pcdh1 and Tcf7l2 are expressed in the mesenchyme. Pcdh1 is expressed
exclusively in the mesenchyme, whereas the others are also expressed in the epithelium. (D) Apoe is expressed in the vascular cells. Parts of the
pancreas epithelia are out lined with dotted line in A-C. Scale bars: 100 μm.
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http://www.biomedcentral.com/1471-213X/11/13
Page 10 of 15Figure 7 The co-expression of candidate genes with insulin, glucagon, Pdx1 or amylase in E14.5 pancreatic bud.( A )C2cd4b co-
expressed with insulin but not glucagon in the trunk (Upper panels). Hipk2 co-expressed with glucagon but not insulin in the epithelium.
Akr1c19 co-expressed with Pdx1 or insulin in the epithelium. (B) Foxp4, Pcbd1 and Aebp2 partly co-expressed with amylase. Scale bar: 100 μm,
applied to A-B.
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such as Mest, Peg3, Col1a2, Tnc, Capn, Gap43 and
Meis1, were up regulated in the d8DE GFP+ cells. These
results therefore suggest that gene expression profiles in
d5, d7 and d8DE were similar with that of E7.5 embryo-
nic DE. However, d7 and d8DE resembled E8.25
embryonic DE compared to d5DE, whereas d8DE
resembled E10.5 embryonic Pdx1+ cells compared to
the other populations.
Genes expressed in endodermal tissues other than the
pancreas
Among the genes whose expression is increased in the
ES cell-derived DE population, several genes are found
to be expressed in the foregut, hindgut or whole gut.
There are genes previously reported to be expressed in
the gut endoderm, or genes with some aspects related
to pancreas endocrine or exocrine functions.
Foxq1, a fork-head transcription factor, was previously
described to be specifically expressed in the stomach in
developing and adult gastrointestinal tract. Mice carry-
ing Foxq1 mutations show absence of mRNA and pro-
tein of the major stomach mucin MUC5AC, and the
mutant mice show a paucity of foveolar cell secretory
vesicles and a notable loss of stomach mucus [20].
CpM, Carboxypeptidase M, is a glycosylphosphatidyli-
nositol (GPI)-anchored membrane protein with B-type
carboxypeptidase activity and is a member of the ‘regu-
latory’ or carboxypeptidase N/E subfamily of metallocar-
boxypeptidases. CpM expression has been described in
the developing and adult lung in Alveolar type I cells
[21,22]. Recently, the expression of CpM was described
to be one of the genes expressed in the Foxa2-expres-
sing endoderm cells [23].
Foxp4, a member of the forkhead box family of
winged-helix genes, is described to be expressed in the
pulmonary, neural and gut tissues during embryonic
development [24]. It was recently reported to mediate
transcriptional repression, by interaction with a compo-
nent of NuRD, and regulate gene expression and epithe-
lial injury response in the lung via regulation of
interleukin-6 [25].
Pcdh1, Protocadherin-1, is a member of the δ-proto-
cadherin subgroup of non-clustered protocadherins. The
expression is described to be especially prominent in
blood vessels in organs derived from the embryonic gut,
such as the esophagus, intestines, liver, lung, and sub-
mandibular glands [26].
Zmiz1,a l s ok n o w na sZmip10, is a member of PIAS
(protein inhibitor of activated STAT) family of genes.
Like the other members of this family, Zmiz1 contains
the zinc-binding SP-RING Zn-finger domain, which
confers SUMO-conjugating activity. At E7.5 Zmiz1 tran-
scripts were generally observed in the epiblast, and
expression was detected in the neuroectoderm, dorsal
aorta and foregut at E8.5 [27]. Taken together, these
results suggest that genes up regulated in the ES cell-
derived DE at d5 and later, or genes up regulated at d8,
are good candidates for being expressed in the gut
endoderm at E8.5 during early embryogenesis. There-
fore, ES cell-derived DE resembles normal early
embryos, and serves as a good source for providing cells
for studies on development.
Genes expressed in the pancreas
Since the differentiation procedure for DE at d7 or d8 is
in favor of pancreatic differentiation, there turned out to
be many genes expressed in the pancreatic bud. Parm1,
Riken cDNA 9130213B05, is one of the top ranked 73
genes whose expression is decreased in Pdx1 mutant
mice in the E10.5 dorsal pancreatic bud [6]. Tmem184,
also described as Sdmg1, is a component of secretory
granules in mouse secretory exocrine tissues, such as
pancreas, salivary gland, and mammary gland. Its
expression in the developing pancreas was recently
reported [28]. homeodomain-interacting protein kinas
(HIPK)-2, is expressed in the embryonic and adult pan-
creas and positively regulates Pdx1 transcriptional activ-
ity by directly phosphorylating the C-terminal portion of
Pdx1 [29]. Nptx2 is one of genes reported with aberrant
DNA methylation in familial pancreatic cancers [30].
Tcf7l2,a l s ok n o w na sTCF-4,i sac o m p o n e n to ft h e
canonical Wnt signaling pathway. A strong genetic asso-
ciation relationship between Tcf7l2 polymorphisms and
type 2 diabetes mellitus was identified [31]. Tcf7l2 was
shown to be involved in stimulating the proliferation of
pancreatic b-cells and the production of the incretin
hormone glucagon-like peptide-1 in intestinal endocrine
L cells [32]. Silencing of TCF7L2 in human and mouse
islets results in a decrease in glucose-stimulated insulin
secretion and increased beta cell apoptosis [33,34].
Similarly, variants at C2cd4b loci are associated with
reduced glucose-stimulated b cell function [35]. Sox4,a
gene of a member of the homeodomain and basic helix-
loop-helix families of transcription factors, is expressed
in developing mouse pancreas [36]. Sox4 reportedly has
ar o l ei ni n s u l i ns e c r e t i o ni nt h ea d u l tb-cell down-
stream of the KATP channel, and is identified as a risk
factor for diabetes and obesity [37,38]. Kiss1r,a l s o
known as GPR54, is expressed in the islets and in b
(MIN5) and a (alphaTC1) cell lines [39]. Kisspeptin, a
novel peptide as endogenous ligand of Kiss1r, plays a
crucial role in puberty and reproductive function [40],
and potentiates glucose-induced insulin secretion from
isolated islets [41].
Most genes listed here are revealed for the first time
to be expressed at this early stage of E8.5 and E14.5. It
is of interest that genes responsible for b-cell maturation
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works examining their function would reveal their role
in replication or differentiation of the pancreas. These
results again highlight the usefulness of the ES cell-
derived cells for the discovering of genes that have a
role in the development and function of the pancreas.
Genes found for the first time to be expressed in the
definitive endoderm or pancreas
There are genes that have never reported to be
expressed in the DE or the pancreas. Akr1c19 is an
aldo-keto reductase family 1 member C19 [42]. Aebp2
encodes a zinc finger protein that has been shown to
interact with the mammalian Polycomb Repression
Complex2 (PRC2) [43]. Its Drosophila homolog, jing,i s
a zinc-finger transcription factor that interacts with the
fly Polycomb Group (PcG) protein complexes, and plays
an essential role in controlling CNS midline and tra-
cheal cell differentiation [44]. Pbxip1 is a PBX interact-
ing protein, also known as HPIP, inhibits the binding of
Pbx1-Hox complexes to DNA [45]. Creb3l1,a l s ok n o w n
as OASIS, is a ZIP (basic leucine zipper) transcription
factor, which is a member of the CREB/ATF family, has
a transmembrane domain, and has been identified as an
ER stress transducer [46]. The physiological functions of
these genes in normal pancreatic development remain
to be explored.
Finally, there are genes whose expression we could not
detect in the Pdx1+ cells during normal pancreatic
development. This might be due to their low expression
levels and/or technical limitation. In addition, some of
the genes show expression patterns that are difficult to
be catalogued at E14.5, since the pancreatic differentia-
tion undergoes a secondary transition at this stage and
many genes show a dramatic change in their expression
patterns after the secondary transition.
Conclusions
Taken together, our data show that ES cell in vitro dif-
ferentiation is an excellent model system for studies of
early developmental processes. ES cell-derived DE cells
or Pdx1/GFP-expressing cells obtained from M15 based
differentiation procedure mimic cells of the normal
developmental processes. Markers identified will be use-
ful for the elucidation of the pancreatic development.
This data will also help to derive cells from ES cells that
are useful for therapeutics.
Methods
Cell lines
The mouse ES cell line, SK7, containing a Pdx1 promo-
ter-driven GFP reporter transgene, and the mesonephric
M15 cells were cultured and differentiated as previously
described [12-14,47].
Differentiation of ES cells
For mesendoderm (MES), definitive endoderm (DE) dif-
ferentiation and pancreatic differentiation, ES cells were
cultured for 4, 5 or 8 days on M15 added with 20 ng/ml
recombinant human activin-A and 50 ng/ml human
bFGF, respectively. For neuroectoderm (ECT) differen-
tiation, ES cell culture on M15 was supplemented with
10 μM SB203580 (a MAPK inhibitor). For lateral plate
mesoderm (LPM) or paraxial mesoderm (PAM) differen-
tiation, ES cell culture on M15 was supplemented with
BMP7 at 25 ng/ml. Isolation of ES cell-derived ECT,
M E S ,a n dm e s o d e r m( P A M + L P M )c e l l sw a sp e r f o r m e d
as previously described [14]. Briefly, MES, DE and meso-
derm were isolated as E-cadherin+/PDGFRa+, E-cad-
herin+/Cxcr4+, and E-cadherin- and Flk1+ or PDGFRa
+ fraction, respectively, by cell sorting. Ectoderm cells
were isolated as PDGFRa-/Flk1-/SSEA1-. The result of
ectoderm differentiation using Sox1/GFP ES cells
indicated that over 90% of sorted PDGFRa-/Flk1-/
SSEA1- cells grown on M15 cell with SB203580 are
Sox1-positive neuroectoderm cells (Additional file 1).
Flow cytometry analysis
Cells were dissociated with Cell Dissociation Buffer
(Invitrogen, Carlsbad, CA) and adjusted to 1 × 10
6 cells/
50 μl and stained with appropriate antibodies. The fol-
lowing antibodies were used: biotin- or Alexa 488-
conjugated anti-E-cadherin monoclonal antibody (mAb)
ECCD-2, biotin- or phycoerythrin (PE)-conjugated anti-
CXCR4 mAb 2B11 (BD Pharmingen, San Diego, CA),
PE-conjugated anti-SSEA1 mAb (R&D Systems), PE-
conjugated anti-FLK1 mAb AVAS12 (BD Biosciences
Pharmingen, San Diego, CA), biotin-conjugated anti-
PDGFRa mAb APA5 (BD Pharmingen) and streptavi-
din-allophycocyanin (BD Pharmingen). The stained cells
were analyzed using a FACS Canto (BD Pharmingen) or
purified with FACS Aria (BD Pharmingen). Data were
recorded using the BD FACSDiva Software program
(BD Pharmingen) and analyzed using the Flowjo pro-
gram (Tree Star, Ashland, OR).
Growth factors and inhibitors
The following concentrations were used: recombinant
human activin-A (R&D Systems), 20 ng/ml. Human
bFGF (Peprotech), 50 ng/ml; recombinant human
BMP7 (R&D Systems), 25 ng/ml; SB203580 (Calbio-
chem), 10 μM.
Microarray analysis
The biotinylated cRNAs from differentiated ES cells
were hybridized with a MOE430 2.0 series probe array
(GeneChip, Affymetrix). Thef l u o r e s c e n c ei n t e n s i t yo f
each probe was quantified using the GeneChip Analysis
Suite 5.0 computer program (Affymetrix). Data from
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sis was performed using the GeneSpring GX software
program version 7.3 (Agilent).
Quantitative RT (Reverse transcription) - real time PCR
(polymerase chain reaction)
RNA was extracted from ES cells using TRI Reagent
(Sigma) or RNeasy micro-kit (Qiagen) and then treated
with DNase (Sigma). Three micrograms of RNA was
reverse-transcribed using MMLV reverse transcriptase
(Toyobo) and oligo dT primers (Toyobo). The primer
sequences are shown in Additional file 2. The transcript
was quantified with SyberGreen on an ABI 7500 thermal
cycler (Applied Biosystems). The PCR conditions were
as follows: denaturation at 95°C for 15 sec, annealing
and extention at 60°C for 60 sec, for up to 40 cycles.
Transcripts were normalized to ß-actin by subtracting
the average ß-actin Ct values (Threshold Cycle) from
the average Ct of transcripts, resulting in Ct. Target
mRNA levels were determined by standard curve
method and expressed as arbitrary units.
In situ hybridization
For whole mount in situ hybridization, embryos were
fixed with 4% paraformaldehyde overnight, dehydrated
in methanol, treated with proteinase K at 10 μg/ml for
10 min, and then refixed in 0.2% glutaraldehyde/4% par-
aformaldehyde. Hybridization were performed with
Digoxigenin (DIG) (Roche) labeled antisense RNA
probes at 1 μg/ml. Plasmids for RNA probes were pur-
chased from Open Biosystems or RIKEN BioResource
Center (Tsukuba).
For in situ hybridization on sections, embryos were
fixed with 4% paraformaldehyde overnight, replaced
with 30% sucrose in PBS 4˚C overnight and embedded
in OCT compound (Sakura Fine technical Co.). In situ
hybridization with digoxigenin-labeled probes was per-
formed on 10 μm frozen section as described [48,49].
Immunocytochemistry
The following antibodies were used: goat anti-Amylase
(Santa Cruz Biotechnology Inc., Santa cruz, CA), rabbit
anti-GFP (MBL International Corp., Woburn, MA),
mouse anti-insulin (Sigma-Aldrich), guinea pig anti-glu-
cagon (Linco Research., St.Charles, MO).
Additional material
Additional file 1: Flow cytometric analyses of ES cell-derived cells of
each cell population. (A) D4 MES (E-cadherin-/PDGFRa+). (B) D5
Mesoderm: PAM (E-cadherin-/PDGFRa+/Flk1-) and LPM (E-cadherin-/
PDGFRa+/Flk1-). (C) D5DE (E-cadherin+/CXCR4+), (D) D5 ECT (SSEA1-/
Flk1-/PGFRa-), then sorted with Sox1/GFP (X-axis), plotted against FSC
(Forward scatter; Y-axis). (E) D7DE (E-cadherin+/CXCR4+), (F) D8DE (E-
cadherin+/CXCR4+), then sorted with Pdx1/GFP (X-axis), plotted against
E-cadherin (Y-axis). Cells collected as the indicated cell population are
shown in blue squares (A, left panel in B, C-F), or in the quadrants (right
panel in B). The percentages of the collected cell populations are
displayed.
Additional file 2: List of primers used for quantitative real-time PCR.
Additional file 3: A comparisons with E7.5 endoderm enriched
genes (versus other germ layers) (Gu et al., Development, 2004).
Additional file 4: A comparison with E8.25 endoderm enriched
genes (Sherwood et al., Developmental biology, 2007).
Additional file 5: A comparison with E10.5 Pdx1+ cells enriched
genes (Gu et al., Development, 2004).
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